ℹ️ Compiled from public regulatory records · Last regulator revision: January 16, 2026🚩 Report this page
Ferrosoferric Phosphate
Active ingredient
Sold as Pulmo Echinacea · Bambusa Pulsatilla · D-124 · FERRUM PHOSPHORICUM 6X
US FDA
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral, Sublingual
- Markets covered
- 1
- Products on record
- 5
- FDA reports (12 mo)
- 81
Overview
Ferrosoferric Phosphate is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 5 | January 16, 2026 |
USUnited States· FDA
5 products
Uses
INDICATIONS
Colds, bladder irritation.
How to take
Sources & citations
- [1]FDA DailyMed · 04d46621-9654-4b… · revised January 13, 2025 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.